Recent evidence points to asyn misfolding and cell-to-cell transmission as critical to neurodegeneration in
Parkinson’s Disease (PD) and Dementia with Lewy Bodies (DLB). Key steps implicated in asyn spread include
release, uptake, misfolding, and impaired protein degradation, yet the key molecular mechanisms that regulate
asyn spread are poorly understood. Rab proteins are small GTPase proteins that control protein trafficking and
degradation and have been implicated in asyn pathogenesis. Among the Rab proteins, Rab27b is highly
expressed at synaptic terminals in neurons in key brain areas affected in PD and DLB. Rab27b regulates synaptic
vesicle (SV) exocytosis and recycling. In non-neuronal cells, Rab27b regulates the distal transport of lysosomes.
We recently showed elevated Rab27b levels in asyn models and in human PD and DLB. Furthermore, we
observed that Rab27b KD increases asyn toxicity by disrupting autophagic flux - pointing to a protective role for
Rab27b in cells with high intracellular asyn burden. Surprisingly, the effects of Rab27b were different in the asyn
fibril model, in which neurons were exposed to extracellular asyn fibrils: Rab27 KO reduced fibrillary asyn uptake
to prevent asyn inclusions and neuronal loss. Based on these data, we hypothesize that Rab27b plays two
critical yet potentially opposing roles in asyn handling: 1) Rab27b promotes asyn autophagic-lysosomal
degradation, yet 2) Rab27b can facilitate endocytosis of pathologic, extracellular asyn as part of its role in SV
recycling. Early in disease, we propose that Rab27b upregulation is neuroprotective: Rab27b aids intracellular
asyn clearance. Yet, as disease progresses and extracellular asyn levels increase, Rab27b’s role in SV
endocytosis becomes maladaptive, overcoming any protective function in protein degradation, and aids asyn
cell-to-cell transmission. Our proposed studies will examine the impact of Rab27b and its interactors on two
critical biological processes implicated in asyn pathogenesis. In Aim 1, we will test the mechanisms by which
Rab27b promotes clearance of intracellular asyn, and examine its interactions with other proteins involved in
autophagic-lysosomal function. In Aim 2, we will elucidate the mechanisms by which Rab27b aids asyn entry
into neurons and determine its interaction with other synaptic trafficking proteins to mediate this effect. In Aim 3,
we will test the overall consequences of Rab27b on asyn pathology over time in two in vivo asyn models. A
greater understanding of the network of proteins that shape asyn transmission will have significant impact on the
development of future therapies for PD and DLB.